We are live on ! Find out more
CCM

Callodine Capital Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 8.74%
This Fund
S&P 500
This Quarter Est. Return
+4.04%
1 Year Est. Return
+8.74%
3 Year Est. Return
+43.6%
5 Year Est. Return
+40.63%
10 Year Est. Return
–
AUM
$265M
AUM Growth
+$34.6M
Cap. Flow
+$23.7M
Cap. Flow %
8.95%
Top 10 Hldgs %
48.44%
Holding
44
New
8
Increased
17
Reduced
14
Closed
3

Top Buys

Rank Stock Value
1
HAE icon
Haemonetics
HAE
+$7.08M
2
ARES icon
Ares Management
ARES
+$6.32M
3
VST icon
Vistra
VST
+$6.02M
4
C icon
Citigroup
C
+$5.18M
5
GILD icon
Gilead Sciences
GILD
+$3.67M

Top Sells

Rank Stock Value
1
DXC icon
DXC Technology
DXC
+$5.35M
2
NEM icon
Newmont
NEM
+$5.19M
3
SBH icon
Sally Beauty Holdings
SBH
+$4.27M
4
KKR icon
KKR & Co
KKR
+$4.15M
5
FSKR
FS KKR Capital Corp. II
FSKR
+$4M

Sector Composition

Rank Sector Weight
1 Financials 50.24%
2 Healthcare 17.08%
3 Consumer Staples 6.81%
4 Technology 5.89%
5 Communication Services 5.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OBDC icon
26
Blue Owl Capital
OBDC
$5.61B
$4.21M 1.59%
295,010
+70,010
+31% +$1.01M
MOS icon
27
The Mosaic Company
MOS
$7.45B
$3.99M 1.51%
125,000
-10,000
-7% -$339K
ET icon
28
Energy Transfer Partners
ET
$71.2B
$3.46M 1.3%
325,000
-25,000
-7% -$240K
MPT
29
Medical Properties Trust
MPT
$2.76B
$3.32M 1.25%
+165,000
New +$3.53M
CCAP icon
30
Crescent Capital BDC
CCAP
$433M
$3.28M 1.24%
175,000
+34,366
+24% +$637K
SAH icon
31
Sonic Automotive
SAH
$2.68B
$3.09M 1.17%
+69,117
New +$3.35M
TAP icon
32
Molson Coors Class B
TAP
$7.95B
$2.82M 1.06%
52,500
-5,000
-9% -$279K
OCSL icon
33
Oaktree Specialty Lending
OCSL
$1.12B
$2.68M 1.01%
133,333
+58,333
+78% +$1.17M
DXC icon
34
DXC Technology
DXC
$1.77B
$1.95M 0.73%
50,000
-150,000
-75% -$5.35M
BCSF icon
35
Bain Capital Specialty
BCSF
$839M
$1.68M 0.64%
110,000
-75,000
-41% -$1.18M
BOX icon
36
Box
BOX
$4.41B
$1.28M 0.48%
+50,000
New +$1.17M
DEA
37
Easterly Government Properties
DEA
$1.18B
$949K 0.36%
+18,000
New +$951K
CHE icon
38
Chemed
CHE
$7.18B
$593K 0.22%
+1,250
New +$600K
GLPI icon
39
Gaming and Leisure Properties
GLPI
$12.8B
$556K 0.21%
+12,000
New +$552K
SBH icon
40
Sally Beauty Holdings
SBH
$1.51B
$441K 0.17%
20,000
-202,500
-91% -$4.27M
MIT
41
DELISTED
Mason Industrial Technology, Inc.
MIT
$290K 0.11%
29,991
+14,291
+91% +$139K
KKR icon
42
KKR & Co
KKR
$92.8B
– –
-85,000
Closed -$4.15M
SAR icon
43
Saratoga Investment
SAR
$317M
– –
-106,473
Closed -$2.7M
FSKR
44
DELISTED
FS KKR Capital Corp. II
FSKR
– –
-205,000
Closed -$4M
1
2

Similar funds

TS
Triglav Skladi Ljubljana, Slovenia $1.43B AUM 39.24% 1-Year Est. Return
SCA
Stonebridge Capital Advisors St Paul, Minnesota $1.43B AUM 21.98% 1-Year Est. Return
SC
Styrax Capital New York $1.43B AUM 50.63% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 28.88% 1-Year Est. Return
KGI
Kopernik Global Investors Tampa, Florida $1.43B AUM 63.57% 1-Year Est. Return
WIM
Weitz Investment Management Omaha, Nebraska $1.43B AUM 0.51% 1-Year Est. Return
APCM
Alaska Permanent Capital Management Anchorage, Alaska $1.43B AUM 13.12% 1-Year Est. Return
KCMH
Kontiki Capital Management (HK) Hong Kong $1.43B AUM 9.81% 1-Year Est. Return

Callodine Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Callodine Capital Management held 44 positions worth $265M, up 15% from $230M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Callodine Capital Management deployed $23.7M of net new capital in Q2 2021, opening 8 new positions and adding to 17 existing holdings. Its largest new stake was Haemonetics: 100,000 shares worth $6.66M.

By sector, the portfolio is most concentrated in Financials at 50% of assets, up from 46% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was DXC Technology, an estimated $5.35M trimmed.

  • Callodine Capital Management's largest Q2 2021 buy was Haemonetics: 100,000 shares worth $6.66M.
  • Callodine Capital Management added most to Ares Management in Q2 2021, an estimated $6.32M increase.
  • Callodine Capital Management's biggest Q2 2021 reduction was DXC Technology, cutting an estimated $5.35M.
  • Callodine Capital Management fully exited KKR & Co in Q2 2021, selling an estimated $4.15M.
  • Callodine Capital Management's ten largest holdings make up 48% of its $265M portfolio in Q2 2021.
  • Callodine Capital Management opened 8 new positions and closed 3 in Q2 2021.
  • Callodine Capital Management's portfolio value rose 15% quarter-over-quarter to $265M.

Based on Callodine Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.